Skip to content

Efficacy of Vitamin C Administration for the Prevention of Postpolypectomy Bleeding

Efficacy of Vitamin C Administration for the Prevention of Postpolypectomy Bleeding

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03400020
Enrollment
156
Registered
2018-01-17
Start date
2018-01-28
Completion date
2018-09-30
Last updated
2018-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpolypectomy Bleeding

Brief summary

Postpolypectomy bleeding is the most common major complication following a colonoscopic polypectomy procedure. The incidence rate ranging from 0.3 to 6.1%. Several preventive methods such as detachable snare and adrenaline injection have been proposed in the management of postpolypectomy bleeding in large colonic polyps. It has been demonstrated that administration of ascorbic acid (vitamin C) in abdominal surgeries could reduce the blood loss during the procedure, operation time and days of hospitalization. So the investigators designed a prospective, randomized study to compares the efficacy of vitamin C administration with application of prophylactic clip and detachable snare in the prevention of postpolypectomy bleeding in large polyps.

Detailed description

In this prospective, randomized clinical trial, patients diagnosed with colon polyps with a diameter \> 10 mm will randomized to receive either a 500 mg vitamin C in normal saline injection or a normal saline injection 2 hours before polypectomy. This administration will continued for 3 days after polypectomoy. Postpolypectomy bleeding is defined either as (1) early: occurring either during an endoscopic procedure or immediately after as hematochezia within 24 h or (2) delayed: any bleeding event that occurring between day 2 and day 30 following the polypectomy procedure.

Interventions

OTHERAscorbic acid

Ascorbic acid 500 Mg in normal saline IV two hours before the operation and thereafter 500 mg in normal saline IV daily for three days.

OTHERNormal Saline

Normal saline IV two hours before the operation and thereafter for three days.

Sponsors

Ilam University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Colorectal polyps larger than 10 mm.

Exclusion criteria

bleeding tendency poor preparation

Design outcomes

Primary

MeasureTime frameDescription
Early postpolypectomy bleedingup to 24 hoursbleeding occurring either during an endoscopic procedure or immediately after as hematochezia within 24 hours following the polypectomy procedure.
Late postpolypectomy bleedingbetween day 2 and day 30bleeding occurring between day 2 and day 30 following the polypectomy procedure.

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026